[TEVA] QoQ Quarter Result on 30-Sep-2019 [#Q3]

Stock
[TEVA] Teva Pharmaceutical Industries Limited
Announcement Date
07-Nov-2019
Financial Year
2019
Quarter
30-Sep-2019 [#Q3]
Profit Trend
QoQ- 54.43%
YoY- -50.96%
Quarter Report
TEVA's Result
TEVA's Financial Summary
View:
Show?
Quarter Result
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
Revenue 3,870,000 4,357,000 4,468,000 4,264,000 4,337,000 4,295,000 4,559,000 -10.35%
PBT -51,000 -33,000 -38,000 -292,000 -850,000 -84,000 -3,387,000 -93.91%
Tax -104,000 -59,000 -119,000 11,000 -179,000 9,000 -139,000 -17.59%
NP 140,000 69,000 109,000 -314,000 -689,000 -105,000 -2,886,000 -
Tax Rate - - - - - - - -
Total Cost 3,730,000 4,288,000 4,359,000 4,578,000 5,026,000 4,400,000 7,445,000 -36.94%
Ratio Analysis
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
NP Margin 3.62 1.58 2.44 -7.36 -15.89 -2.44 -63.30 -
Per Share
30/06/20 31/03/20 31/12/19 30/09/19 30/06/19 31/03/19 31/12/18 CAGR
EPS 0.13 0.06 0.10 -0.29 -0.63 -0.10 -2.80 -
EPS Diluted 0.13 0.06 0.10 -0.29 -0.63 -0.10 -2.80 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.